Table 1.
Clinical characteristics and circulating endothelial progenitor cells (EPC) levels of ovarian cancer patients
| Clinical characteristic | Patients (n) | EPCs (per ml) | P |
|---|---|---|---|
| Age | NS | ||
| <43 years old | 17 | 1154 ± 93.7 | |
| ≥43 years old | 25 | 1205 ± 178.5 | |
| Residual tumor size | 0.029 | ||
| <2 cm | 22 | 523 ± 92.6 | |
| ≥2 cm | 8 | 875 ± 192.6 | |
| FIGO stage | 0.034 | ||
| I--II | 8 | 1023 ± 104.2 | |
| III--IV | 34 | 1450 ± 206.5 | |
| Histological subtype | NS | ||
| Serous | 23 | 1165 ± 254.6 | |
| Mucinous | 13 | 1187 ± 223.7 | |
| Endometrioid | 6 | 1235 ± 198.4 | |
| Therapy | NS | ||
| Chemotherapy | 12 | 783.4 ± 162.5 | |
| Surgery | 30 | 605 ± 147.2 |
FIGO, Federation of Obstetrics and Gynecology; NS, not significant. Data are expressed as mean ± SE.